Intarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The companyâ€™s products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.
Current Team (10)Update
Vice President, Development and Manufacturing
Chief Medical Officer
Executive Director, Product Development
Executive Director, DUROS® Manufacturing
Vice President, Commercial Operations
Chairman of the Board, President & CEO
Chief Business Officer and Head of Corporate Development
Executive Director, Regulatory Compliance and Quality Assurance
Funding Rounds (8) - $534.3MUpdate
Board Members and Advisors (4)Update
UNIQUE VISION UNCOMMON PERSPECTIVE Main focus is intensive, original, bottom-up, fundamental...
Health-Care Focused VC Firm
Farallon Capital Management, L.L.C. is an American capital management firm that manages funds on...
Growth equity - healthcare
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences...
Quilvest, listed on the Luxembourg Stock Exchange, is a global institution with a long history...
Venrock is a venture capital firm investing in technology and healthcare companies.
Global venture capital firm helping entrepreneurs build transformational businesses across...
155 Seaport Boulevard
24650 Industrial Boulevard
Hayward, CA 94545